Skip to main content

Peer Review reports

From: The value of serum neutralizing antibody in evaluating predictability of COVID-19 after recovery and the validation of vaccine

Original Submission
21 Jul 2022 Submitted Original manuscript
15 Oct 2022 Reviewed Reviewer Report
11 Nov 2022 Reviewed Reviewer Report - Mohammad Barary
22 Dec 2022 Author responded Author comments - Jing Wang
Resubmission - Version 2
22 Dec 2022 Submitted Manuscript version 2
3 Jan 2023 Reviewed Reviewer Report
14 Jan 2023 Reviewed Reviewer Report - Mohammad Barary
29 Mar 2023 Author responded Author comments - Jing Wang
Resubmission - Version 3
29 Mar 2023 Submitted Manuscript version 3
12 Apr 2023 Author responded Author comments - Jing Wang
Resubmission - Version 4
12 Apr 2023 Submitted Manuscript version 4
22 Apr 2023 Author responded Author comments - Jing Wang
Resubmission - Version 5
22 Apr 2023 Submitted Manuscript version 5
26 Apr 2023 Author responded Author comments - Jing Wang
Resubmission - Version 6
26 Apr 2023 Submitted Manuscript version 6
4 May 2023 Author responded Author comments - Jing Wang
Resubmission - Version 7
4 May 2023 Submitted Manuscript version 7
11 May 2023 Reviewed Reviewer Report
2 Jul 2023 Author responded Author comments - Jing Wang
Resubmission - Version 8
2 Jul 2023 Submitted Manuscript version 8
Publishing
15 Jul 2023 Editorially accepted
20 Dec 2023 Article published 10.1186/s12879-023-08465-9

You can find further information about peer review here.

Back to article page